Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: A cohort study

Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: A cohort study

<p>Abstract</p> <p>Background</p> <p>Reasons for the variation in reported treatment outcomes from antiretroviral therapy (ART) programmes in developing countries are not clearly defined.</p> <p>Methods</p> <p>Among ART-naïve individuals in a wor...

Full description

Bibliographic Details
Main Authors:	Martin Des J, Pemba Lindiwe F, Stenson Amy L, Charalambous Salome, Fielding Katherine L, Wood Robin, Churchyard Gavin J, Grant Alison D
Format:	Article
Language:	English
Published:	BMC 2008-07-01
Series:	BMC Infectious Diseases
Online Access:	http://www.biomedcentral.com/1471-2334/8/93

Similar Items

Second-line antiretroviral therapy in a workplace and community-based treatment programme in South Africa: determinants of virological outcome.
by: Victoria Johnston, et al.
Published: (2012-01-01)

Low haemoglobin predicts early mortality among adults starting antiretroviral therapy in an HIV care programme in South Africa: a cohort study
by: Churchyard Gavin J, et al.
Published: (2010-07-01)

Contrasting predictors of poor antiretroviral therapy outcomes in two South African HIV programmes: a cohort study
by: Hamilton Robin, et al.
Published: (2010-07-01)

"That is why I stopped the ART": Patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme
by: Kielmann Karina, et al.
Published: (2008-02-01)

Comparison of tenofovir, zidovudine, or stavudine as part of first-line antiretroviral therapy in a resource-limited-setting: a cohort study.
by: Kavindhran Velen, et al.
Published: (2013-01-01)

Cytomegalovirus viremia as a risk factor for mortality prior to antiretroviral therapy among HIV-infected gold miners in South Africa.
by: Katherine Fielding, et al.
Published: (2011-01-01)

The diagnostic accuracy of urine lipoarabinomannan test for tuberculosis screening in a South African correctional facility.
by: Yasmeen Hanifa, et al.
Published: (2015-01-01)

High tuberculosis prevalence in a South African prison: the need for routine tuberculosis screening.
by: Lilanganee Telisinghe, et al.
Published: (2014-01-01)

Monitoring the virological response to antiretroviral therapy in Africa
by: John, Laurence Michael
Published: (2007)

Incidence of HIV-associated tuberculosis among individuals taking combination antiretroviral therapy: a systematic review and meta-analysis.
by: Tendesayi Kufa, et al.
Published: (2014-01-01)

Kinetics and Determining Factors of the Virologic Response to Antiretrovirals during Pregnancy
by: Adriana Weinberg, et al.
Published: (2009-01-01)

Pregnancy and virologic response to antiretroviral therapy in South Africa.
by: Daniel Westreich, et al.
Published: (2011-01-01)

Association of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults.
by: Portia C Mutevedzi, et al.
Published: (2011-01-01)

Virological efficacy and emergence of drug resistance in adults on antiretroviral treatment in rural Tanzania
by: Holberg-Petersen Mona, et al.
Published: (2009-07-01)

Virological and immunological stabilisation in AIDS-presenter, regardless antiretroviral therapy
by: Roberto Manfredi
Published: (2010-06-01)

Evaluating a minipool strategy to screen for virologic failure and antiretroviral drug resistance
by: H.M. Newman, et al.
Published: (2014-04-01)

Sustained virological response on second-line antiretroviral therapy following virological failure in HIV-infected patients in rural South Africa.
by: Annelot F Schoffelen, et al.
Published: (2013-01-01)

Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya.
by: Julie Kadima, et al.
Published: (2018-01-01)

Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda.
by: Pontiano Kaleebu, et al.
Published: (2015-01-01)

Empiric tuberculosis treatment in South African primary health care facilities - for whom, where, when and why: Implications for the development of tuberculosis diagnostic tests.
by: Kerrigan McCarthy, et al.
Published: (2018-01-01)

Virological outcomes and drug resistance in Chinese patients after 12 months of 3TC-based first-line antiretroviral treatment, 2011-2012.
by: Jing Wang, et al.
Published: (2014-01-01)

Virologic response to efavirenz-based first-line antiretroviral therapy in children with previous exposure to antiretrovirals to prevent mother-to-child transmission.
by: Patience Nyakato, et al.
Published: (2020-01-01)

Correction: Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya.
by: Julie Kadima, et al.
Published: (2019-01-01)

Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052.
by: Philip J Palumbo, et al.
Published: (2017-01-01)

Virological Breakthrough: A Risk Factor for Loss to Followup in a Large Community-Based Cohort on Antiretroviral Therapy
by: Catherine Orrell, et al.
Published: (2011-01-01)

Dolutegravir: Virologic response and tolerability of initial antiretroviral regimens for adults living with HIV.
by: Analú Correa, et al.
Published: (2020-01-01)

Virologic outcome among patients receiving antiretroviral therapy at five hospitals in Haiti.
by: Frantz Jean Louis, et al.
Published: (2018-01-01)

Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007.
by: Marie Ballif, et al.
Published: (2009-01-01)

Long-term virological outcome in children receiving first-line antiretroviral therapy
by: Padmapriyadarsini Chandrasekaran, et al.
Published: (2018-11-01)

Factors associated with virological suppression to antiretroviral therapy among people living with HIV
by: Hui-ChenChu, et al.
Published: (2014)

Virologic suppression in response to antiretroviral therapy despite extensive resistance within HIV-1 reverse transcriptase after the first virologic failure
by: Marta Iglis Oliveira, et al.
Published: (2018-10-01)

Immunologic and Virologic Outcomes of Obese and Nonobese Incarcerated Adults on Antiretroviral Therapy for HIV Infection
by: Kristen L. Bunnell PharmD, et al.
Published: (2018-01-01)

Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting
by: Lawn Stephen D, et al.
Published: (2008-07-01)

Bullying in the Bahamian Workplace
by: William J. Fielding
Published: (2020-10-01)

Bullying in the Bahamian Workplace
by: William J. Fielding
Published: (2020-10-01)

Antiretroviral adherence and virologic suppression in partnered and unpartnered HIV-positive individuals in southern Brazil.
by: Marineide Gonçalves de Melo, et al.
Published: (2019-01-01)

Virological suppression in children and adolescents is not influenced by genotyping, but depends on optimal adherence to antiretroviral therapy
by: Juliana Costa de Abreu, et al.
Published: (2017-05-01)

Simplified Assessment of Antiretroviral Adherence and Prediction of Virological Efficacy in HIV-Infected Patients in Cambodia
by: Olivier Segeral, et al.
Published: (2010-01-01)

Studying the Causes of Virologic Failure in the Early Stages of Antiretroviral Therapy in HIV-Infected Patients
by: M.H. Liulchuk
Published: (2015-02-01)

Long-term clinical, immunological and virological outcomes of patients on antiretroviral therapy in southern Myanmar.
by: Elkin Hernán Bermúdez-Aza, et al.
Published: (2018-01-01)